aTyr Pharma Ownership | Who Owns aTyr Pharma?
aTyr Pharma Ownership Summary
aTyr Pharma is owned by 72.42% institutional investors, 2.62% insiders, and 24.96% retail investors. Federated hermes is the largest institutional shareholder, holding 22.20% of LIFE shares. Federated Hermes Kaufmann Growth is the top mutual fund, with 11.38% of its assets in aTyr Pharma shares.
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Federated hermes | 14.67M | 22.20% | $22.88M |
Fmr | 10.35M | 15.67% | $16.15M |
Logos global management lp | 3.00M | 4.54% | $4.68M |
Vanguard group | 2.65M | 4.01% | $4.14M |
Tikvah management | 2.46M | 3.72% | $3.84M |
Checkpoint capital | 1.95M | 2.95% | $3.04M |
Alyeska investment group | 1.87M | 2.83% | $2.91M |
Woodline partners lp | 1.68M | 2.55% | $2.63M |
Blackrock | 1.39M | 2.11% | $2.17M |
Renaissance | 1.29M | 1.96% | $2.02M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Checkpoint capital | 1.95M | 1.83% | $3.04M |
Tikvah management | 2.46M | 1.25% | $3.84M |
Ghost tree capital | 800.00K | 0.39% | $1.25M |
Logos global management lp | 3.00M | 0.38% | $4.68M |
Tang capital management | 671.13K | 0.11% | $1.05M |
Federated hermes | 14.67M | 0.05% | $22.88M |
Gsa capital partners llp | 322.46K | 0.04% | $503.00K |
Woodline partners lp | 1.68M | 0.03% | $2.63M |
Alyeska investment group | 1.87M | 0.02% | $2.91M |
Alterna wealth management | 10.00K | 0.01% | $15.60K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Federated hermes | 14.67M | 0.05% | 4.50M |
Fmr | 10.35M | 0.00% | 1.43M |
Adage capital partners gp | 1.00M | 0.00% | 1.00M |
Checkpoint capital | 1.95M | 1.83% | 500.00K |
Alyeska investment group | 1.87M | 0.02% | 362.08K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Octagon capital advisors lp | - | - | -700.00K |
Barclays | - | - | -604.30K |
Superstring capital management lp | - | - | -313.03K |
Goldman sachs group | - | - | -217.23K |
Marshall wace, llp | - | - | -158.62K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Adage capital partners gp | 1.00M | 0.00% | 1.00M | $1.56M |
Sachetta | 150.00 | 0.00% | 150.00 | $297.00 |
Strategic investment solutions, inc. /il | 8.00 | - | 8.00 | $16.00 |
Sold Out
Holder | Change |
---|---|
Cypress capital | -200.00 |
Two sigma investments, lp | -10.09K |
Verition fund management | -12.68K |
Prudential financial | -16.00K |
Two sigma securities | -17.49K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 58 | 18.37% | 47,854,387 | -0.56% | 72 | 1.37% | 29 | - | 12 | - |
Jun 30, 2024 | 49 | -15.52% | 48,123,606 | 15.11% | 72 | 1.20% | 29 | -19.44% | 12 | 20.00% |
Mar 31, 2024 | 58 | 20.83% | 41,806,011 | 1.40% | 77 | 1.54% | 36 | 50.00% | 10 | - |
Dec 31, 2023 | 48 | 9.09% | 41,229,924 | 11.03% | 71 | 1.57% | 24 | 60.00% | 10 | -44.44% |
Sep 30, 2023 | 44 | -2.22% | 37,134,555 | 4.11% | 67 | 0.93% | 15 | -50.00% | 18 | 157.14% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Federated Hermes Kaufmann Growth | 7.85M | 11.38% | 3.06M |
Federated Hermes Kaufmann Small Cap Grow | 6.62M | 9.59% | 1.36M |
Federated Hermes Kaufmann Small Cap A | 5.26M | 7.63% | - |
Federated Hermes Kaufmann R | 4.79M | 6.93% | - |
Fidelity Growth Compy Commingled Pl O | 3.70M | 5.37% | 4.71K |
Fidelity Growth Company Fund | 2.62M | 3.80% | -8.95K |
Fidelity Select Biotechnology | 2.26M | 3.27% | - |
Vanguard Total Stock Mkt Idx Inv | 1.75M | 2.53% | - |
Fidelity Growth Company K6 | 1.03M | 1.49% | 4.24K |
Vanguard Institutional Extnd Mkt Idx Tr | 787.41K | 1.14% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
May 30, 2024 | COUGHLIN TIMOTHY | - | Buy | $87.50K |
May 31, 2024 | Broadfoot Jill Marie | Chief Financial Officer | Buy | $8.95K |
May 31, 2024 | Shukla Sanjay | President and CEO | Buy | $36.14K |
Feb 06, 2024 | Broadfoot Jill Marie | Chief Financial Officer | Sell | $2.69K |
Dec 12, 2023 | Shukla Sanjay | President and CEO | Buy | $14.14K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q2 | - | - |
2024 Q1 | - | 1 |
2023 Q4 | 4 | - |
2023 Q3 | 1 | - |
2023 Q2 | 1 | - |
LIFE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools